Polakis, Paul
Genentech, Inc,
United States
2024 Rank: 4683
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 225 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4683 | 5517 |
| Total Cites | 23256 | 24071 |
| H-index | 63 | 65 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 6300 | 6352 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 6727 | 6798 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 16422 | 16746 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15836 | 16133 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.49 |
| Self-Citation Percentage |
3.39%
|
|
Polakis, Paul
Genentech, Inc,
United States
2023 Rank: 4392
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 223 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4392 | 5210 |
| Total Cites | 22659 | 23464 |
| H-index | 62 | 64 |
| Hm-index | 23 | 23 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 6187 | 6239 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 6608 | 6679 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 16171 | 16493 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15348 | 15642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.50 |
| Self-Citation Percentage |
3.43%
|
|
Polakis, Paul
Genentech Incorporated,
United States
2022 Rank: 3769
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 199 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3769 | 4767 |
| Total Cites | 21942 | 22730 |
| H-index | 62 | 62 |
| Hm-index | 23 | 23 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 6030 | 6082 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 6445 | 6516 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 15823 | 16146 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14789 | 15074 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.51 |
| Self-Citation Percentage |
3.47%
|
|
Polakis, Paul
Genentech Incorporated,
United States
2021 Rank: 3732
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 202 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3732 | 4557 |
| Total Cites | 21394 | 22173 |
| H-index | 61 | 61 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 5904 | 5956 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 6313 | 6383 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 15488 | 15808 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14399 | 14680 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.51 |
| Self-Citation Percentage |
3.51%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.